1. Market Research
  2. > Healthcare Market Trends

The Reality of Market Access in Europe: the role of Health Technology Assessment

  • March 2014
  • 82 pages
  • Firstword Pharma
Report ID: 3509425

Summary

Table of Contents




Faced with slipping or negligible GDP growth and an economic crisis, Eurozone countries are drilling down into healthcare budgets as a means of controlling expenditure.

From price cuts, tighter reimbursement criteria and greater patient co-payments to the wider use of generics and manufacturer risk-sharing agreements, the largest markets are examining ways to balance the public good with fiscal goals.

Set against that background is Health Technology Assessment (HTA). Widely used as part of the pricing and reimbursement process in Europe, HTA is nevertheless still in the early stages of being coordinated into a system across Europe.

In The Reality of Market Access in Europe: the role of Health Technology Assessment, FirstWord skilfully addresses the issues surrounding HTA, both for its potential to rationalise treatment on economic grounds and as a means to assess the cost effectiveness of new products. Focused on the agencies, procedures and approaches of HTA in the six largest EU markets, the report provides a coherent and current overview of pricing and reimbursement, controversies over issues like rule-making and individual product cases, and what the future of HTA will look like.












Key Benefits

Attitudes to drug reimbursement have been shaped by economics. In The Reality of Market Access in Europe: the role of Health Technology Assessment, you will:


Understand how economic uncertainties are affecting pharmaceutical reimbursement spending
Gain insight into how HTA has become more formalised and transparent in recent years
Know which countries have the most advanced HTA systems and why
Understand how HTA can provide a more certain route to market, and raise the bar for new drugs entering the market

Filled with compelling and important insights into an evolving market, the report offers:

Up-to-date charts and figures, translated European sources and insights into the HTA process
A look at different approaches—and outcomes—in the top six EU markets
Insight on how HTA affects market access for new drugs, and the additional information HTA agencies demand
Insight into moves to co-ordinate HTA approaches across the EU
Discussion of how health budgets are affected by the EU’s current economic reality


Key Questions Answered

How have national attitudes towards drug reimbursement been shaped by economic realities?
Which countries have the most advanced HTA systems and which countries are following the lead?
How have HTA reforms created market hurdles?
What changes in information provision now affect manufacturers?
How can HTA increase access to new drugs?
How have coordinating moves at EU level affected the conduct of the HTA process?







Key facts

Despite worsening economic circumstances, health spending accounts for a greater proportion of the GDP in France, Germany, Italy, Poland, Spain and the United Kingdom than in 2009.
Expensive medicines are more widely distributed in European countries, along with specific high-cost therapy areas such as cancer.
Although established in 2006, the EUnetHTA is still in the early stages of harmonising HTA approaches across the Eurozone.


Content Highlights
Pharmaceutical manufacturers are increasingly faced with changing rules and practices on reimbursement. In this report, you will discover:

The role of the key governing agencies and how they operate in six key European markets
How the downward pressure of cost containment is being met with the upward push from patient groups for the latest products
The most up-to-date and expertly translated charts and data



Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 60 Million searchable statistics with tables, figures & datasets
  • More than 25,000 trusted sources
  • Single User License — provides access to the report by one individual.
  • Department License — allows you to share the report with up to 5 users
  • Site License — allows the report to be shared amongst all employees in a defined country
  • Corporate License — allows for complete access, globally.

Veronica helps you find the right report:

Testimonials

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

We were impressed with the support that ReportLinker’s research specialists’ team provided. The report we purchased was useful and provided exactly what we want.

Category Manager at
Ikea

ReportLinker gave access to reliable and useful data while avoiding dispersing resources and spending too much time on unnecessary research.

Executive Director at
PwC Advisory

The customer service was fast, responsive, and 100% professional in all my dealings (...) If we have more research needs, I'll certainly prioritize working with ReportLinker!

Scott Griffith

Vice President Marketing at
Maurice Sporting Goods

The research specialist provided prompt, helpful instructions for accessing ReportLinker's product. He also followed up to make sure everything went smoothly and to ensure an easy transition to the next stage of my research

Jessica P Huffman

Research Associate at
American Transportation Research Institute

Excellent customer service. Very responsive and fast.

Director, Corporate Strategy at
Ingredion

I reached out to ReportLinker for a detailed market study on the Air Treatment industry. The quality of the report, the research specialist’s willingness to solve my queries exceeded my expectations. I would definitely recommend ReportLinker for in-depth industry information.

Mariana Mendoza

Global Platform Senior Manager at
Whirlpool Corporation

Thanks! I like what you've provided and will certainly come back if I need to do further research works.

Bee Hin Png

CEO at
LDR Pte Ltd

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

Purchase Reports From Reputable Market Research Publishers

Infectious Disease Testing Market 2021: A 74-Country Analysis--Supplier Shares and Strategies, Test Volume and Sales Segment Forecasts, Technology and Instrumentation Review

  • $ 59500
  • Industry report
  • May 2017
  • by Venture Planning Group

This unique 68-country survey from VPGMarketResearch.com provides data and analysis not available from any other published source. The survey is designed to assist diagnostics industry executives, as well ...

Virology and Bacteriology Testing Market 2021: A 68-Country Analysis--Supplier Shares and Strategies, Test Volume and Sales Segment Forecasts, Technology and Instrumentation Review

  • $ 59500
  • Industry report
  • June 2017
  • by Venture Planning Group

This unique 68-country survey from VPGMarketResearch.com provides data and analysis not available from any other published source. The survey is designed to assist diagnostics industry executives, as well ...

Automated Microbiology Market 2021: A 68-Country Analysis--Supplier Shares and Strategies, Volume and Sales Segment Forecasts for 100 Molecular Diagnostic, Microbial Identification

  • $ 52500
  • Industry report
  • June 2017
  • by Venture Planning Group

This new 74-country survey from VPGMarketResearch.com provides granular data and analysis not available from any other published source. The survey is designed to help current suppliers and potential market ...


Download Unlimited Documents from Trusted Public Sources

Hospital Statistics in the UK

  • June 2017
    28 pages
  • Hospital  

    Infectious Dise...  

    Infection Contr...  

  • United Kingdom  

View report >

Hospital Industry in the UK - Forecast

  • June 2017
    65 pages
  • Hospital  

  • United Kingdom  

View report >

Healthcare Industry in the UK

  • June 2017
    36 pages
  • Smoking Statist...  

    Child Health  

    Risky Behaviour  

  • United Kingdom  

View report >

Healthcare Industry

7 hours ago

ref:plp2014

Reportlinker.com © Copyright 2017. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.